Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn caters to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. The company has manufacturing facilities in India and the US. It operates in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.
Headquarters
United States of America
Address
Suite 300, 1925 West Field Court, Lake Forest, Illinois, 60045
Website
www.akorn.com
Telephone
1 800 9325676
Industry
Pharmaceuticals and Healthcare
Explore premium data & analytics
Products and Services
| Products | Brands |
|---|---|
| Prescription Pharmaceuticals: | Vancocin |
| Atropine Sulfate Ophthalmic Solution | Prometrium |
| Clobetasol Propionate Cream | Protonix |
| XXX | XXX |
| XXX | XXX |
| XXX | XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Contracts/Agreements | In January, the company entered into an agreement to sell seven branded ophthalmic products to Thea. |
| 2021 | Contracts/Agreements | In May, the company entered into an agreement to sell its consumer health business to an affiliate of Prestige Consumer Healthcare Inc for US$230 million. |
| 2021 | Regulatory Approval | In February, the company obtained a new ANDA approval from the US FDA for Loteprednol Etabonate Ophthalmic Gel, 0.5%. |
Competitor Comparison
| Key Parameters | Akorn Inc | Johnson & Johnson | Pfizer Inc | Bausch Health Companies Inc | Fresenius Kabi AG |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Canada | Germany |
| City | Lake Forest | New Brunswick | New York | Laval | Bad Homburg |
| State/Province | Illinois | New Jersey | New York | Quebec | Hessen |
| No. of Employees | - | 141,700 | 79,000 | 19,600 | 40,519 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Robert Webster | Chairman | Executive Board | 2021 | - |
| Douglas S. Boothe | Chief Executive Officer; Director; President | Executive Board | 2019 | 56 |
| Duane A. Portwood | Chief Financial Officer; Executive Vice President | Senior Management | 2015 | 53 |
| Randall E. Pollard | Senior Vice President; Controller - Corporate; Chief Accounting Officer | Senior Management | 2015 | 48 |
| Jonathan Kafer | Chief Commercial Officer | Senior Management | 2018 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer